~ Total Assets of $2.2 Billion and Over $2 Billion in Financial Assets* ~ ~ $17.9 Million Cash Provided by Operating Activities with Fourth Consecutive Quarter of Positive Operating Cash Flow ~ ~ Truth Social, Truth+ Enhancements Continue as TMTG Moves toward Prospective Merger with TAE Technologies ~ SARASOTA, Fla., May 08, 2026 (GLOBE NEWSWIRE) — Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) (“TMTG” or the “Company”), operator of the social media platform Truth Social, the video streaming service Truth+, and the financial services and FinTech brand Truth.Fi, is announcing its financial results for the fiscal quarter ending on March 31, 2026, and is filing its Form 10-Q with the Securities and Exchange Commission (the “SEC”) today. TMTG closed the first quarter of 2026 with total assets of $2.2 billion and financial...

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Q1 2026 Financial Highlights (1):Revenues of $762.0 million Gross Margin at 17.0% EBITDA (2) amounted to $68.1 million Net Earnings amounted to $23.9 million Quarterly dividend of $0.14 per share declared (4)VANCOUVER, British Columbia, May 08, 2026 (GLOBE NEWSWIRE) — Doman Building Materials Group Ltd. (“Doman” or “the Company”) (TSX:DBM) announced today its first quarter 2026 financial results (1) for the period ended March 31, 2026. For the three-month period ended March 31, 2026 (1), consolidated revenues totaled $762.0 million, compared to $793.2 million in 2025, largely due to the impact of decreases in pricing on a year-over-year basis across certain...

FARGO, N.D., May 08, 2026 (GLOBE NEWSWIRE) — NI Holdings, Inc. (NASDAQ: NODK) announced today results for the quarter ended March 31, 2026. Summary of First Quarter 2026 Results(All comparisons vs. the first quarter of 2025, unless noted otherwise)Gross premiums written of $57.5 million compared to $67.8 million in the prior year quarter. This decrease was driven by Non-Standard Auto (-99.8%) reflecting the continued impact of the Company’s strategic decision to cease writing this business in Illinois, Arizona and South Dakota, as well as a decline in Private Passenger Auto (-7.0%) due to lower renewal premiums resulting from underwriting actions in prior years. These declines were partially offset by growth in Home and Farm (+7.3%) driven by rate increases, higher insured values, and new business in North Dakota and South Dakota,...

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – Phase 3 protocol submitted with FDA feedback expected imminently; incremental data submitted to ENDO2026 and ASBMR EB612, the first oral long-acting PTH peptide replacement tablet for hypoparathyroidism – Expanded 50/50 partnership with OPKO; intention to file IND in late 2026; data submitted to ENDO2026 EB618, the first oral OXM (dual GLP-1/Glucagon) tablet for metabolic and fibrotic conditions – data submitted to ENDO2026 Direct Investment led by BVF Partners L.P. to support EB613 pivotal study acceleration and working capital TEL AVIV, May 08, 2026 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today reported financial...

— With fertility rates at historic lows, Femasys advances access to early infertility care through FemaSeed® Complete, enabling OB/GYNs to treat patients within their own practices — ATLANTA, May 08, 2026 (GLOBE NEWSWIRE) —  Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announces its financial results for the quarter ended March 31, 2026 and provides a corporate update. Corporate Highlights from 1Q 2026 to dateAdvanced initial commercial adoption of FemaSeed Complete, positioning Femasys to expand access to first-line fertility treatment through integrated, in-office care by OB/GYNs, supporting earlier intervention prior to referral to higher-cost specialty care. Launched FemaSeed Complete...

FREDERICK, Md., May 08, 2026 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Ionization Technology® (BIT™) platform, today announced financial results for the three months ended March 31, 2026, and provided an update on strategic initiatives. Most significantly, the Company recently announced a non-binding letter of intent to merge with Carbonium Core, Inc., a U.S.-based producer of nuclear-grade graphite for advanced reactor technologies and AI data center infrastructure, representing a transformative new chapter for TOMI. Landmark Post-Quarter Development: Letter of Intent with Carbonium Core, Inc. On April 30, 2026, the Company executed a non-binding letter of intent (the “LOI”) to merge with Carbonium Core,...